Skip Navigation
Skip to contents



10 results

Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports

Lim JK, Ahn JB, Cheon SH, Chang H, Jung JY, Rha SY, Roh JK, Noh SH, Kim HG, Chung HC, Jeung HC

  • Cancer Res Treat.
  • 2006 Jun;38(3):184-188.
Surgical resection of colorectal cancer metastasis to the liver results in a 5-year survival rate of around 40%. Liver metastasis from other cancers such as neuroendocrine carcinoma and genitourinary tumors...
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors of the Stomach: Report of Three Cases

Oh JS, Lee JL, Kim MJ, Ryu MH, Chang HM, Kim TW, Jang SJ, Yook JH, Oh ST, Kim BS, Kang YK

  • Cancer Res Treat.
  • 2006 Jun;38(3):178-183.
Neoadjuvant imatinib therapy used to treat locally advanced or metastatic gastrointestinal stromal tumors (GI ST) remains under active investigation. We studied three cases of locally advanced gastric GISTs treated with...
Cell Cycle Regulatory Protein Expression Profiles by Adenovirus p53 Infection in Human Papilloma Virus-associated Cervical Cancer Cells

Lee YS, Bae SM, Kwak SY, Park DC, Kim YW, Hur SY, Park EK, Han BD, Lee YJ, Kim CK, Kim DK, Ahn WS

  • Cancer Res Treat.
  • 2006 Jun;38(3):168-177.
PURPOSE: The tumor suppressor gene, p53, has been established as an essential component for the suppression of tumor cell growth. In this study, we investigated the time-course anticancer effects of...
The Synergism between Belotecan and Cisplatin in Gastric Cancer

Jung JY, Song SH, Kim TY, Park JH, Jong HS, Im SA, Kim TY, Bang YJ, Kim NK

  • Cancer Res Treat.
  • 2006 Jun;38(3):159-167.
PURPOSE: We wanted to demonstrate the anti-cancer effect and interaction between belotecan and cisplatin on gastric cancer cell line and we evaluated the mechanisms of this synergistic effect in vitro....
Inhibition of Phorbol Ester-induced Mouse Skin Tumor Promotion and COX-2 Expression by Celecoxib: C/EBP as a Potential Molecular Target

Chun KS, Kundu JK, Park KK, Chung WY, Surh YJ

  • Cancer Res Treat.
  • 2006 Jun;38(3):152-158.
PURPOSE: Inflammation acts as a driving force for the development of cancer. Multiple lines of evidence suggest that nonsteroidal anti-inflammatory drugs, especially those that specifically target cyclooxygenase-2 (COX-2), are effective...
AKAP12alpha is Associated with Promoter Methylation in Lung Cancer

Jo U, Whang YM, Kim HK, Kim YH

  • Cancer Res Treat.
  • 2006 Jun;38(3):144-151.
PURPOSE: Promoter methylation is an important mechanism for silencing tumor-suppressor genes in cancer and it is a promising tool for the development of molecular biomarkers. The purpose of the present...
Occludin Expression in Brain Tumors and its Relevance to Peritumoral Edema and Survival

Park MW, Kim CH, Cheong JH, Bak KH, Kim JM, Oh SJ

  • Cancer Res Treat.
  • 2006 Jun;38(3):139-143.
PURPOSE: Peritumoral brain edema (PTBE) is a serious causative factor that contributes the morbidity or mortality of brain tumors. The development of PTBE is influenced by many factors, including such...
Patterns of Failure after Postoperative Radiation Therapy for Endometrial Carcinoma

Kim S, Wu HG, Lee HP, Kang SB, Song YS, Park NH, Ha SW

  • Cancer Res Treat.
  • 2006 Jun;38(3):133-138.
PURPOSE: We tried to investigate the outcome and patterns of failure of endometrial cancer patients who were treated with surgery and postoperative radiation therapy (RT). MATERIALS AND METHODS: Eighty-three patients...
Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage Breast Cancers

Kim Y, Kim SY, Lee JJ, Seo J, Kim YW, Koh SH, Yoon HJ, Cho KS

  • Cancer Res Treat.
  • 2006 Jun;38(3):126-132.
PURPOSE: Obesity-related leptin and leptin receptor (OBR) have a relation to the development of cancer and metastasis and also the low survival rate for breast cancer patients. Leptin has been...
A Pilot Study of Cisplatin, Irinotecan, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric Cancer

Park SH, Jeon SY, Ko KI, Nam E, Bang SM, Cho EK, Shin DB, Lee JH, Lee WK, Chung M

  • Cancer Res Treat.
  • 2006 Jun;38(3):121-125.
PURPOSE: Irinotecan, in combination with leucovorin/ 5-fluorouracil (FU) or with cisplatin, is known to be active for treating advanced gastric cancer (AGC). This pilot study evaluated a novel three-drug combination...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: